Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenz

Showing results (331-340 of 367) with videos related to

Pageof 37
Sort By:
The Pharmacogenomics Journal|October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancerL Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancerM Suenaga, M Schirripa, S Cao, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancerY Sunakawa, S Stremitzer, S Cao, et al.
The Pharmacogenomics Journal|October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trialsA Sebio, S Stintzing, V Heinemann, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2013
KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapiesM K H Maus, P P Grimminger, P C Mack, et al.
Journal of Clinical Gastroenterology|November 9, 2016
Esophagorespiratory Fistulas: Survival and Outcomes of TreatmentCharles J Lenz, Benjamin L Bick, David Katzka, et al.
The Pharmacogenomics Journal|October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancerY Sunakawa, S Cao, M D Berger, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patientsB Waldrup, F Carranza, Y Jin, et al.
British Journal of Cancer|May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisY S Lee, I Choi, Y Ning, et al.
Pageof 37

Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
The Pharmacogenomics Journal|October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancerL Benhaim, W Zhang, T Wakatsuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancerM Suenaga, M Schirripa, S Cao, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancerY Sunakawa, S Stremitzer, S Cao, et al.
The Pharmacogenomics Journal|October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trialsA Sebio, S Stintzing, V Heinemann, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2013
KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapiesM K H Maus, P P Grimminger, P C Mack, et al.
Journal of Clinical Gastroenterology|November 9, 2016
Esophagorespiratory Fistulas: Survival and Outcomes of TreatmentCharles J Lenz, Benjamin L Bick, David Katzka, et al.
The Pharmacogenomics Journal|October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancerY Sunakawa, S Cao, M D Berger, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patientsB Waldrup, F Carranza, Y Jin, et al.
British Journal of Cancer|May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisY S Lee, I Choi, Y Ning, et al.
Pageof 37